ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years
Yashwardhan Ghanwatkar
Matched on ORCID iD 0000-0003-2214-4147; OpenAlex author ID A5037406191. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2024: 1 paper · 2025: none · 2026: 2 papers
Papers 3
- Dual Inhibition of KRAS G12D and PI3K/BRD4 signaling overcomes therapeutic resistance in pancreatic cancer. Co-author DOI 10.1016/j.actbio.2025.12.049↗
- Desmoplasia and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218618↗
- Recent advances in drug delivery and targeting for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2023.12.053↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ram I. Mahato · 3 shared papers, 2024–2026 · strength 1.17
- Paper Desmoplasia and therapeutic resistance in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218618↗
- Paper Dual Inhibition of KRAS G12D and PI3K/BRD4 signaling overcomes therapeutic resistance in pancreatic cancer. DOI 10.1016/j.actbio.2025.12.049↗
- Paper Recent advances in drug delivery and targeting for the treatment of pancreatic cancer. DOI 10.1016/j.jconrel.2023.12.053↗
- Nilkamal Pramanik · 1 shared paper, 2024 · strength 0.31
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.